Mekinist
Term · Oncology and biomedicine · MLC-T-ONC-005223
A drug used alone or with dabrafenib to treat low-grade glioma (a type of brain tumor) in children aged 1 year and older and certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Mekinist blocks proteins called MEK1 and MEK2, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called trametinib dimethyl sulfoxide.
| Identifier | MLC-T-ONC-005223 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | trametinib dimethyl sulfoxide |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005223",
"term": "Mekinist",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with dabrafenib to treat low-grade glioma (a type of brain tumor) in children aged 1 year and older and certain types of anaplastic thyroid cancer, non-small cell lung cancer, melanoma, and other solid tumors that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Mekinist blocks proteins called MEK1 and MEK2, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called trametinib dimethyl sulfoxide.",
"synonyms": [
"trametinib dimethyl sulfoxide"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mekinist/"
}
Record 10,783 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.